Balyasny Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.02M | Buy |
+334,294
| New | +$5.02M | 0.01% | 896 |
|
|
2025
Q1 | – | Sell |
-103,850
| Closed | -$1.64M | – | 2342 |
|
|
2024
Q4 | $1.64M | Buy |
103,850
+44,955
| +76% | +$710K | ﹤0.01% | 1145 |
|
|
2024
Q3 | $936K | Buy |
+58,895
| New | +$936K | ﹤0.01% | 1343 |
|
|
2024
Q2 | – | Sell |
-76,890
| Closed | -$1.13M | – | 2330 |
|
|
2024
Q1 | $1.13M | Buy |
76,890
+40,205
| +110% | +$590K | ﹤0.01% | 1229 |
|
|
2023
Q4 | $511K | Sell |
36,685
-31,880
| -46% | -$444K | ﹤0.01% | 1421 |
|
|
2023
Q3 | $917K | Sell |
68,565
-16,715
| -20% | -$224K | ﹤0.01% | 1168 |
|
|
2023
Q2 | $1.08M | Buy |
+85,280
| New | +$1.08M | ﹤0.01% | 1218 |
|
|
2022
Q4 | – | Sell |
-28,730
| Closed | -$301K | – | 2669 |
|
|
2022
Q3 | $301K | Buy |
+28,730
| New | +$301K | ﹤0.01% | 1722 |
|
|
2018
Q4 | – | Sell |
-139,995
| Closed | -$969K | – | 1521 |
|
|
2018
Q3 | $969K | Buy |
+139,995
| New | +$969K | ﹤0.01% | 971 |
|